Evidence map›Paper›PMID 41367065›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2025

Virtual Pet-Assisted Therapy to Alleviate Symptoms of Long COVID: A Prospective Pilot Interventional Study.

Ruka Kamo, Taiju Miyagami, Mizue Saita, Nanami Hara, Yuichiro Mine, Tsubasa Nishina, Yukiko Fukui, Yoshinao Harada, Mihoko Niitsuma, Toshio Naito

Abstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruka KamoDepartment of General Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Taiju MiyagamiDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan.ORCID 0000-0002-4893-2224
Mizue SaitaDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Nanami HaraDepartment of Precision Mechanics, Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
Yuichiro MineDepartment of General Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Tsubasa NishinaDepartment of General Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Yukiko FukuiDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Yoshinao HaradaDepartment of Personalized Kampo Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan.ORCID 0000-0001-7760-138X
Mihoko NiitsumaDepartment of Precision Mechanics, Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
Toshio NaitoDepartment of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan.ORCID 0000-0003-1646-9930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Post-COVID-19 condition (long COVID) is characterized by persistent symptoms following acute infection. Given the limited efficacy of pharmacologic treatments, there is growing interest in complementary, non-contact interventions. Virtual pet-assisted therapy (VAT), a virtual reality-based adaptation of animal-assisted therapy, may offer a novel strategy for symptom management in this population. MATERIAL AND METHODS A prospective intervention was conducted in the long COVID clinic at Juntendo University Hospital between July and December 2023. Adult patients with long COVID engaged with a virtual dog for 10 minutes prior to their clinical consultation. Twelve symptoms considered potentially responsive to short-term intervention were self-rated on a 10-point scale before and after the session, with scores representing mean values. RESULTS Forty-two participants (median age: 46 years; 71.4% female) were included in the analysis. The mean total symptom score decreased by 7.2%, from 34.6 points before the intervention to 32.1 points after (P=0.004). Fatigue scores decreased by 9.5% (from 6.3 to 5.7, P=0.004), dyspnea decreased by 17% (from 2.3 to 1.9, P=0.038), memory impairment decreased by 13% (from 4.8 to 4.2, P=0.015), and tinnitus decreased by 22% (from 2.3 to 1.8, P=0.012). CONCLUSIONS VAT could be a feasible and well-tolerated intervention worth further investigation as a potential adjunct for alleviating key symptoms of long COVID, particularly those with psychological components. Although this preliminary study is limited by the lack of a control group, it serves as a pilot study that demonstrates the potential of VAT.

Indexed as

Animal Assisted TherapyCOVID-19AdultAgedAnimalsDogsFatigueFemaleHumansMaleMiddle AgedPilot ProjectsPost-Acute COVID-19 SyndromeProspective StudiesSARS-CoV-2

Identifiers

PMID41367065
PMCPMC12755280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.